Design Therapeutics, Inc.
DSGN • NASDAQ
Design Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Pratik Shah, with a market cap of $770.3M.
Market Cap$770.3M
Employees57.0
CEOPratik Shah
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 6, 2026 · In 3 weeksQ1 2026
Financials
Design Therapeutics, Inc. FAQ
Common questions about Design Therapeutics, Inc.
Design Therapeutics, Inc. is scheduled to report earnings for Q1 2026 on May 6, 2026.
Design Therapeutics, Inc. has approximately 57 employees.